AJCN Cancer Health Disparities Conference
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by te Braake, F. W.
Right arrow Articles by van Goudoever, J. B
PubMed
Right arrow PubMed Citation
Right arrow Articles by te Braake, F. W.
Right arrow Articles by van Goudoever, J. B
Agricola
Right arrow Articles by te Braake, F. W.
Right arrow Articles by van Goudoever, J. B
American Journal of Clinical Nutrition, Vol. 88, No. 2, 333-339, August 2008
© 2008 American Society for Nutrition


ORIGINAL RESEARCH COMMUNICATION

Glutathione synthesis rates after amino acid administration directly after birth in preterm infants1,2,3

Frans WJ te Braake, Henk Schierbeek, Karien de Groof, Andras Vermes, Mariangela Longini, Giuseppe Buonocore and Johannes B van Goudoever

1 From the Department of Pediatrics, Division of Neonatology (FWJtB, HS, KdG, and JBvG), and Department of Clinical Pharmacy (AV) Erasmus MC–Sophia Children's Hospital, Rotterdam, Netherlands; the Department of Pediatrics, Obstetrics and Reproductive Medicine, University of Siena, Siena, Italy (ML and GB)

Background: The availability of glutathione, the main intracellular antioxidant, is compromised in preterm neonates. A possible explanation is the low availability of substrate for synthesis, because many neonatologists are reluctant to administer amino acids in the direct postnatal period for fear of intolerance.

Objective: The objective of the study was to determine the effects of amino acid administration directly after birth on glutathione synthesis rates and markers of oxidative stress.

Design: Premature infants (<1500 g) received from birth onward either dextrose (control group; n = 10) or dextrose plus 2.4 g amino acids · kg – 1 · d–1 (intervention group; n = 10). On postnatal day 2, [1-13C]glycine was administered to determine glutathione fractional synthesis rates (FSRGSH) and absolute synthesis rates (ASRGSH) in erythrocytes. In plasma, advanced oxidized protein products and dityrosine, both markers of oxidative stress, were measured. The results are expressed as means ± SDs.

Results: The FSRGSH was not different between groups: 44 ± 6 and 48 ± 9%/d in the control and intervention groups, respectively (P = 0.28). The concentration of erythrocyte glutathione was higher (P < 0.001) in the intervention group (2.28 ± 0.35 mmol/L) than in the control group (1.73 ± 0.37 mmol/L). ASRGSH values were 6.5 ± 1.5 and 11.3 ± 1.9 mg · kg–1 · d–1 in the control and intervention groups, respectively (P < 0.001). Advanced oxidized protein products and dityrosine concentrations were not significantly different between groups.

Conclusions: Amino acid administration directly after birth increases ASRGSH in preterm infants. Our data are consistent, however, with higher glutathione concentrations rather than a higher FSRGSH. Greater availability of glutathione, nevertheless, did not decrease markers of oxidative stress.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by The American Society for Nutrition